cerebral palsy: A group of disorders affecting the development of movement and posture, often accompanied by disturbances of sensation, perception, cognition, and behavior. It results from damage to the fetal or infant brain.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
659 |
4. Check minimum number of eventsNone |
659 |
5. Include endpointsNone |
659 |
6. Filter based on genotype QC (FinnGen only) |
659 |
Control definitions (FinnGen only)
- Control exclude
- G6_CPETAL
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- G80-G83
- Name in latin
- Paralysis cerebralis infantilis
Similar endpoints
↥List of similar endpoints to
Cerebral palsy
based on the number of shared cases.
Similar with more cases:
- Cerebral palsy and other paralytic syndromes
- Neurological diseases
- Neurological diseases, wide definition
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 13423 | 5771 | 7608 |
| Only index persons | 10731 | 4719 | 6012 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.19 | 0.17 | 0.21 |
| Only index persons | 0.20 | 0.17 | 0.23 |
| Median age at first event (years) | |||
| Whole population | 4.66 | 4.71 | 4.29 |
| Only index persons | 4.37 | 4.68 | 4.12 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 659 | 344 | 315 |
| Unadjusted period prevalence (%) | 0.13 | 0.12 | 0.14 |
| Median age at first event (years) | 4.97 | 5.57 | 4.32 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 611
- Matched controls
- 6109
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G80.1
ICD-10 Finland
Spastic diplegic cerebral palsy
+∞
178.1
162
*
G80.2
ICD-10 Finland
Spastic hemiplegic cerebral palsy
+∞
174.6
159
*
G80.9
ICD-10 Finland
Cerebral palsy, unspecified
+∞
128.8
119
*
G80.0
ICD-10 Finland
Spastic quadriplegic cerebral palsy
+∞
103.1
96
*
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
14.7
94.0
167
152
3430A
ICD-9 Finland
Infantile cerebral palsy, Diplegic
+∞
75.6
71
*
M03BX01
ATC
baclofen; systemic
45.6
73.5
90
23
3431A
ICD-9 Finland
Infantile cerebral palsy, Hemiplegic
+∞
70.2
66
*
G40.9
ICD-10 Finland
Epilepsy, unspecified
15.5
65.9
112
87
34300
ICD-8 Finland
Cerebral spastic infantile paralysis, Hemiplegia spastica
+∞
65.8
62
*
34301
ICD-8 Finland
Cerebral spastic infantile paralysis, Diplegia spastica
+∞
61.5
58
*
34309
ICD-8 Finland
Cerebral spastic infantile paralysis, Unspecified
+∞
58.3
55
*
N03AG01
ATC
valproic acid; systemic, rectal
8.0
51.9
126
191
G81.1
ICD-10 Finland
Spastic hemiplegia
+∞
51.8
49
*
N05BA01
ATC
diazepam; systemic, rectal
6.3
51.7
154
312
G81.9
ICD-10 Finland
Hemiplegia, unspecified
+∞
45.4
43
*
SPAT1229
SPAT
Assessment of need for aid
9.6
45.3
97
118
34308
ICD-8 Finland
Cerebral spastic infantile paralysis, Alia definita
+∞
44.3
42
*
G80.8
ICD-10 Finland
Other cerebral palsy
+∞
44.3
42
*
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
7.3
43.8
112
181
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
13.6
42.4
75
62
N99
ICPC
Neurological disease other
55.1
39.1
46
9
N05BA09
ATC
clobazam; oral
19.9
38.3
58
32
G80.3
ICD-10 Finland
Dyskinetic cerebral palsy
+∞
37.9
36
*
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
5.2
37.8
128
294
N03AX14
ATC
levetiracetam; systemic
10.6
36.6
73
77
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
5.0
36.4
128
305
N03AF02
ATC
oxcarbazepine; oral
9.3
35.4
76
92
L28
ICPC
Limited function/disability (L)
5.1
34.8
121
284
N18
ICPC
Paralysis/weakness
40.8
33.8
42
11
183
Kela drug reimbursment
Lamotrigin and topiramate
18.8
33.8
52
30
A28
ICPC
Limited function/disability NOS
5.4
33.2
107
230
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
16.9
33.2
53
34
N28
ICPC
Limited function/disability (N)
32.1
32.1
42
14
3438X
ICD-9 Finland
Infantile cerebral palsy, Other specified infantile cerebral palsy[PARESIS CEREBRALIS INFANTILIS ALIA DEFINITA]
+∞
31.5
30
*
34302
ICD-8 Finland
Cerebral spastic infantile paralysis, Tetraplegia spastica
+∞
30.5
29
*
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
23.0
30.0
43
20
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
13.4
29.6
52
42
G82.4
ICD-10 Finland
Spastic tetraplegia
+∞
29.4
28
*
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
24.3
29.1
41
18
F79.0
ICD-10 Finland
Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour
25.1
28.7
40
17
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
13.2
27.8
49
40
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
5.2
27.7
92
203
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
4.1
27.5
117
332
R56.8
ICD-10 Finland
Other and unspecified convulsions
5.4
26.9
85
177
NFL22
NOMESCO Finland
Myotomy or tenotomy of hip or thigh
97.7
25.9
28
*
N03AF01
ATC
carbamazepine; oral, rectal
7.6
25.4
61
88
G80
ICD-10 Finland
Cerebral palsy
+∞
25.2
24
*
N03AX09
ATC
lamotrigine; oral
5.5
24.7
76
153
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
21.2
24.6
36
18
R4110
NOMESCO Finland
Physiotherapy
2.8
23.3
188
848
N03AE01
ATC
clonazepam; systemic
6.3
23.1
63
109
G40.10
ICD-10 Finland
Simple partial seizures
19.9
22.8
34
18
H47.2
ICD-10 Finland
Optic atrophy
238.5
22.8
23
*
9375
FHL
Achilles tendon dissection or extension
238.5
22.8
23
*
N05CD08
ATC
midazolam; nasal, systemic
9.5
22.2
46
52
WX408
NOMESCO Finland
General anesthesy, balanced
2.6
21.3
195
938
3AX01
NOMESCO Finland
NA
29.3
21.1
28
10
RT150
NOMESCO Finland
NA
14.8
21.1
35
25
ZX114
NOMESCO Finland
Intramuscular
10.6
20.7
40
40
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
26.6
20.6
28
11
N03AG04
ATC
vigabatrin; oral
33.9
20.3
26
8
G91.1
ICD-10 Finland
Obstructive hydrocephalus
49.8
20.3
24
5
G40.89
ICD-10 Finland
Other epilepsy
32.5
19.4
25
8
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.0
19.4
122
463
P85
ICPC
Mental retardation
19.0
19.3
29
16
3439X
ICD-9 Finland
Infantile cerebral palsy, unspecified
+∞
18.8
18
*
G80.4
ICD-10 Finland
Ataxic cerebral palsy
+∞
18.8
18
*
NHL14
NOMESCO Finland
Shortening or lengthening of achilles tendon
24.6
18.8
26
11
37300
ICD-8 Finland
Strabismus, Concomitans convergens
21.7
18.8
27
13
A06AD11
ATC
lactulose; oral
3.7
18.6
86
258
R4120
NOMESCO Finland
Occupational therapy
4.7
18.4
65
152
F82
ICD-10 Finland
Specific developmental disorder of motor function
10.8
18.4
35
34
TJD20
NOMESCO Finland
Change of gastrostomy tube
22.6
18.3
26
12
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
9.1
18.2
38
44
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.6
18.0
158
728
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
29.8
17.5
23
8
N03AX11
ATC
topiramate; oral
6.5
17.5
46
76
N29
ICPC
Neurological sympt/complt other
13.1
17.3
30
24
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
3.5
17.1
86
276
F79.9
ICD-10 Finland
Unspecified mental retardation, without mention of impairment of behaviour
65.2
16.8
19
*
G81.0
ICD-10 Finland
Flaccid hemiplegia
+∞
16.7
16
*
3432A
ICD-9 Finland
Infantile cerebral palsy, Quadriplegic[CP-OIREYHTYMÄ,TETRAPLEGIA SPASTICA]
+∞
16.7
16
*
34409
ICD-8 Finland
Other cerebral paralysis, Unspecified
+∞
16.7
16
*
34304
ICD-8 Finland
Cerebral spastic infantile paralysis, Dystonia tetraplegica. Tonusväxlingssyndrom
+∞
16.7
16
*
M41.4
ICD-10 Finland
Neuromuscular scoliosis
92.6
16.6
18
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.7
16.6
131
568
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
41.3
16.4
20
5
RS142
NOMESCO Finland
NA
31.0
16.2
21
7
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
7.8
16.2
37
50
RT274
NOMESCO Finland
NA
48.9
16.1
19
*
3454A
ICD-9 Finland
Epilepsy, Partial epilepsy, with impairment of consciousness[EPILEPSIA GENERALISATA SECUNDARIA]
48.9
16.1
19
*
R1250
NOMESCO Finland
Evaluation of functional capability
7.7
16.0
37
51
F80.1
ICD-10 Finland
Expressive language disorder
8.3
15.5
34
43
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
5.8
15.4
44
81
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
4.2
15.3
59
151
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.5
15.2
131
594
AA1AD
NOMESCO Finland
CT of head and brain
2.7
15.2
114
478
AA7AA
NOMESCO Finland
Liquor cerebri shunt X-ray examinatin without contrast
46.2
15.1
18
*
H50.30
ICD-10 Finland
Intermittent esotropy
12.9
15.0
26
21
XA800
NOMESCO Finland
Neuropsychological investigation
4.0
15.0
62
169
EBA15
NOMESCO Finland
Extraction of large number of teeth
6.2
14.9
40
68
H50.31
ICD-10 Finland
Intermittent exotropia
9.0
14.9
31
36
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
13.7
14.8
25
19
181
Kela drug reimbursment
Retigabine and vigabatrin
25.8
14.8
20
8
7819X
ICD-9 Finland
Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]
21.7
14.7
21
10
3459X
ICD-9 Finland
Epilepsy, unspecified
153.5
14.5
15
*
XKC03
NOMESCO Finland
Water cystometry
7.7
14.4
33
45
RT490
NOMESCO Finland
NA
17.5
14.4
22
13
G91.0
ICD-10 Finland
Communicating hydrocephalus
27.9
14.3
19
7
NF1DA
NOMESCO Finland
X-ray of hips
10.1
14.3
28
29
F71.0
ICD-10 Finland
Moderate mental retardation, with the statement of no, or minimal, impairment of behaviour
43.6
14.2
17
*
R1260
NOMESCO Finland
Evaluation of communicative skills
9.2
14.1
29
33
G40.4
ICD-10 Finland
Other generalized epilepsy and epileptic syndromes
13.1
14.0
24
19
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.0
14.0
87
323
RT190
NOMESCO Finland
NA
24.4
13.9
19
8
SPAT1215
SPAT
Assessment of need for medical rehabilitation
4.8
13.8
46
102
H50.1
ICD-10 Finland
Divergent concomitant strabismus
15.2
13.7
22
15
3432B
ICD-9 Finland
Infantile cerebral palsy, Quadriplegic[CP-OIREYHTYMÄ,DYSTONIA TETRAPLEGICA]
+∞
13.6
13
*
G82.1
ICD-10 Finland
Spastic paraplegia
+∞
13.6
13
*
H47.7
ICD-10 Finland
Disorder of visual pathways, unspecified
143.0
13.5
14
*
9362
FHL
Adductorotomy
143.0
13.5
14
*
F83
ICD-10 Finland
Mixed specific developmental disorders
6.6
13.4
34
54
G40
ICD-10 Finland
Epilepsy
10.8
13.3
25
24
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
2.8
13.3
91
358
G40.00
ICD-10 Finland
Benign childhood epilepsy with centrotemporal EEG spikes
41.0
13.2
16
*
R1410
NOMESCO Finland
Drawing up a rehabilitation plan
17.2
13.1
20
12
U04
ICPC
Incontinence urine
6.4
12.7
33
54
H53.0
ICD-10 Finland
Amblyopia ex anopsia
8.1
12.7
28
36
34400
ICD-8 Finland
Other cerebral paralysis, Hemiplegia NUD
+∞
12.5
12
*
G40.1
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
24.9
12.5
17
7
NFK30
NOMESCO Finland
Angulation, rotation or displacement osteotomy of femur
20.6
12.5
18
9
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.4
12.5
121
579
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.1
12.4
72
256
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.2
12.3
65
216
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
16.3
12.2
19
12
Z87.6
ICD-10 Finland
Personal history of certain conditions arising in the perinatal period
7.5
12.1
28
39
RS222
NOMESCO Finland
NA
8.2
12.0
26
33
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.9
11.9
74
275
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
4.4
11.9
43
104
JDB10
NOMESCO Finland
Percutaneous gastrostomy
9.2
11.8
24
27
RL140
NOMESCO Finland
NA
10.8
11.8
22
21
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
3.6
11.8
53
156
R33
ICD-10 Finland
Retention of urine
4.9
11.7
38
82
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.1
11.7
164
924
SPAT1234
SPAT
Support of social functional capacity
5.0
11.7
37
78
L89
ICD-10 Finland
Decubitus ulcer and pressure area
19.4
11.6
17
9
N03AX18
ATC
lacosamide; systemic
8.9
11.6
24
28
R62.0
ICD-10 Finland
Delayed milestone
5.1
11.6
36
74
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
7.7
11.5
26
35
G82.2
ICD-10 Finland
Paraplegia, unspecified
+∞
11.5
11
*
R11
ICD-10 Finland
Nausea and vomiting
3.0
11.4
67
240
7803A
ICD-9 Finland
General symptoms, Convulsions
8.6
11.4
24
29
NE1AA
NOMESCO Finland
Pelvis X-ray examination
4.5
11.4
40
94
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.8
11.2
76
297
37301
ICD-8 Finland
Strabismus, Concomitans divergens
17.4
11.2
17
10
SPAT1231
SPAT
Assessment of adjustments needed in living environment
13.0
11.2
19
15
SPAT1262
SPAT
Handing over of treatment supplies
2.5
11.2
94
418
Z02.7
ICD-10 Finland
Issue of medical certificate
3.7
11.1
48
137
N03AX12
ATC
gabapentin; oral
2.6
11.1
82
339
SPAT1216
SPAT
Assessment of functional ability
2.8
11.0
71
270
N85
ICPC
Congenital anomaly neurological
44.1
11.0
13
*
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
8.5
10.9
23
28
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
4.5
10.9
38
89
Z50.1
ICD-10 Finland
Other physical therapy
4.4
10.8
39
94
H54.2
ICD-10 Finland
Moderate visual impairment, binocular
18.2
10.8
16
9
H54.7
ICD-10 Finland
Unspecified visual loss
18.2
10.8
16
9
F70.1
ICD-10 Finland
Mild mental retardation, Significant impairment of behaviour requiring attention or treatment
28.6
10.8
14
5
G91.9
ICD-10 Finland
Hydrocephalus, unspecified
21.9
10.7
15
7
K03.66
ICD-10 Finland
Tooth plaque
2.8
10.7
69
262
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
2.9
10.7
66
245
78159
ICD-8 Finland
Other symptoms referable to nervous system and special senses, Laesio loquendi alia sive NUD
61.1
10.7
12
*
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.6
10.6
48
142
TNX50
NOMESCO Finland
Removal of cutom molded cast and internal stretch
3.7
10.6
46
132
N05AX08
ATC
risperidone; systemic
3.1
10.6
60
210
SPAT1148
SPAT
Treatment of chronic ulcer or burn
3.0
10.5
62
223
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
7.0
10.5
25
37
G82.5
ICD-10 Finland
Tetraplegia, unspecified
+∞
10.4
10
*
34305
ICD-8 Finland
Cerebral spastic infantile paralysis, Ataxia
+∞
10.4
10
*
N88
ICPC
Epilepsy
10.9
10.3
19
18
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.8
10.3
65
245
RS211
NOMESCO Finland
NA
8.7
10.1
21
25
602
Kela drug reimbursment
Children's severe malnutrition
6.3
10.1
26
43
P21.0
ICD-10 Finland
Severe birth asphyxia
40.8
10.0
12
*
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
6.5
9.9
25
40
R47.1
ICD-10 Finland
Dysarthria and anarthria
20.4
9.8
14
7
113
Kela drug reimbursment
Anxiety disorders associated with mental retardation
20.4
9.8
14
7
XXA00
NOMESCO Finland
Clinical examination requiring general anaesthesia
10.9
9.8
18
17
N39.4
ICD-10 Finland
Other specified urinary incontinence
3.9
9.8
39
104
H50.0
ICD-10 Finland
Convergent concomitant strabismus
7.6
9.8
22
30
WX704
NOMESCO Finland
Intubation
3.1
9.8
53
181
R5120
NOMESCO Finland
Preparation of an aid
7.0
9.7
23
34
F72.0
ICD-10 Finland
Severe mental retardation, with the statement of no, or minimal, impairment of behaviour
55.9
9.7
11
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.5
9.6
44
132
G40.11
ICD-10 Finland
Simple partial epileptic seizure that develops into a complex partial seizure
15.3
9.6
15
10
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
4.7
9.5
31
68
R5110
SPAT
NA
7.7
9.5
21
28
RT320
NOMESCO Finland
NA
101.5
9.4
10
*
P22.0
ICD-10 Finland
Respiratory distress syndrome of newborn
17.9
9.4
14
8
R5210
NOMESCO Finland
Assessment of the improvements needed in the living environment
30.5
9.4
12
*
P91.02
ICD-10 Finland
Neonatal hypoxic-ischaemic encephalopathy, severe
+∞
9.4
9
*
NHG22
NOMESCO Finland
Fusion of subtalar joint
22.1
9.4
13
6
NAG53
NOMESCO Finland
Posterior or lateral fusion of thoracic spine with fixation, more than 3 vertebraea
22.1
9.4
13
6
K59.09
ICD-10 Finland
Constipation, unspecified
3.6
9.4
41
119
R60.0
ICD-10 Finland
Localized oedema
3.1
9.3
52
180
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.3
9.2
45
142
H55
ICD-10 Finland
Nystagmus and other irregular eye movements
13.9
9.2
15
11
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
6.9
9.2
22
33
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.5
9.1
73
314
WX892
NOMESCO Finland
Monitored bed care
3.0
9.1
52
183
ZXA05
NOMESCO Finland
Left side
2.1
9.1
113
598
G40.21
ICD-10 Finland
Partial epileptic seizure with cloudiness and automatism
15.9
9.1
14
9
34599
ICD-8 Finland
Epilepsy, Other and unspecified
37.3
9.0
11
*
R4130
NOMESCO Finland
Speech therapy
4.8
9.0
29
63
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
6.2
9.0
23
38
TKC20
NOMESCO Finland
Catheterisation of bladder
3.9
9.0
36
97
JDB00
NOMESCO Finland
Gastrostomy
24.4
8.9
12
5
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.6
8.9
67
280
U07
ICPC
Urine symptom/complaint other
3.6
8.8
38
109
K59.0
ICD-10 Finland
Constipation
3.6
8.7
38
110
G04BD04
ATC
oxybutynin; oral, transdermal
4.5
8.7
30
70
3451A
ICD-9 Finland
Epilepsy, Generalised convulsive epilepsy
50.7
8.7
10
*
3781B
ICD-9 Finland
Strabismus and other disorders of binocular eye movements, Divergent concomitant strabismus[STRABISMUS DIVERGENS ALTERNANS]
50.7
8.7
10
*
TNX34
NOMESCO Finland
Major custom molded cast, unspecified region
5.3
8.6
25
49
N03AX23
ATC
brivaracetam; systemic
27.9
8.5
11
*
AAF25
NOMESCO Finland
Removal of shunt of ventricle of brain
27.9
8.5
11
*
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
7.5
8.5
19
26
A46
ICD-10 Finland
Erysipelas
2.6
8.4
60
242
N05AH04
ATC
quetiapine; oral
2.0
8.4
112
609
N03AB02
ATC
phenytoin; systemic
13.0
8.4
14
11
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.2
8.4
90
446
G04BD08
ATC
solifenacin; oral
4.1
8.4
31
78
34401
ICD-8 Finland
Other cerebral paralysis, Diplegia NUD
+∞
8.3
8
*
Q04.8
ICD-10 Finland
Other specified congenital malformations of brain
+∞
8.3
8
*
7423A
ICD-9 Finland
Other congenital anomalies of nervous system, Congenital hydrocephalus
+∞
8.3
8
*
N05CD07
ATC
temazepam; oral
3.0
8.3
47
165
TLC00
NOMESCO Finland
Insertion of intrauterine device
2.8
8.2
53
203
SPAT1301
SPAT
No procedures
1.8
8.2
173
1108
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
3.8
8.2
33
90
NHL68
NOMESCO Finland
Tenodesis, shortening or lengthening of tendon of foot
8.3
8.1
17
21
N03AA02
ATC
phenobarbital; systemic
33.8
8.1
10
*
R1240
NOMESCO Finland
Social assessment of need and possibilities of rehabilitation
9.1
8.1
16
18
SPAT1260
SPAT
Consultation of another employee
2.1
8.0
96
501
L17
ICPC
Foot/toe symptom/complaint
1.9
8.0
133
787
L16
ICPC
Ankle symptom/complaint
2.3
7.9
78
371
ZXA00
NOMESCO Finland
Right side
1.9
7.9
119
679
N03AX15
ATC
zonisamide; oral
13.2
7.9
13
10
3820A
ICD-9 Finland
Suppurative and unspecified otitis media, Acute suppurative otitis media
4.6
7.8
26
59
R2120
NOMESCO Finland
Counselling and guidance concerning rehabilitation services and social security
11.0
7.8
14
13
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.0
7.8
97
515
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.7
7.8
53
209
A03FA02
ATC
cisapride; oral, rectal
3.1
7.7
40
133
3503
FHL
Single muscle retroposition
15.3
7.7
12
8
F70.9
ICD-10 Finland
Mild mental retardation, Without mention of impairment of behaviour
15.3
7.7
12
8
F71.1
ICD-10 Finland
Moderate mental retardation, significant impairment of behaviour requiring attention or treatment
45.6
7.7
9
*
T85.0
ICD-10 Finland
Mechanical complication of ventricular intracranial (communicating) shunt
45.6
7.7
9
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.6
7.7
56
230
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.1
7.7
92
481
H52.2
ICD-10 Finland
Astigmatism
4.1
7.7
28
70
H53.4
ICD-10 Finland
Visual field defects
6.8
7.6
18
27
AAF00
NOMESCO Finland
Ventriculostomy
18.6
7.6
11
6
P07.2
ICD-10 Finland
Extreme immaturity
25.4
7.6
10
*
P07.3
ICD-10 Finland
Other preterm infants
5.5
7.6
21
39
M21.4
ICD-10 Finland
Flat foot [pes planus] (acquired)
4.8
7.6
24
52
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.0
7.6
41
141
G40.09
ICD-10 Finland
Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset
10.2
7.6
14
14
78020
ICD-8 Finland
Certain symptoms referable to nervous system and special senses, Convulsions
7.3
7.5
17
24
N03AX16
ATC
pregabalin; oral
2.0
7.5
100
544
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
4.3
7.5
26
62
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
3.9
7.5
29
77
N05AH03
ATC
olanzapine; systemic
2.7
7.5
51
202
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
7.4
186
1252
9480
FHL
Tendon shortening and extension
81.0
7.4
8
*
34532
ICD-8 Finland
Epilepsy, Partialis (focalis) generalisata
81.0
7.4
8
*
NHG24
NOMESCO Finland
Fusion of subtalar joint and between bones of ankle
81.0
7.4
8
*
F02.89*G40.9
ICD-10 Finland
Dementia in epilepsy
81.0
7.4
8
*
Z93.1
ICD-10 Finland
Gastrostomy status
81.0
7.4
8
*
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
7.8
7.4
16
21
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.4
7.4
65
294
H47.6
ICD-10 Finland
Disorders of visual cortex
+∞
7.3
7
*
34408
ICD-8 Finland
Other cerebral paralysis, Alia definita
+∞
7.3
7
*
Z99.8
ICD-10 Finland
Dependence on other enabling machines and devices
+∞
7.3
7
*
9372
FHL
Measures for knee flexors
+∞
7.3
7
*
2133
FHL
Suntin revisio
+∞
7.3
7
*
WX882
NOMESCO Finland
High dependency care
3.2
7.3
37
122
G41.9
ICD-10 Finland
Status epilepticus, unspecified
16.0
7.2
11
7
S06.0
ICD-10 Finland
Concussion
2.2
7.2
74
363
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.9
7.2
42
152
H51.9
ICD-10 Finland
Disorder of binocular movement, unspecified
30.4
7.2
9
*
N03AX22
ATC
perampanel; oral
20.3
7.1
10
5
WX002
NOMESCO Finland
Sedation and analgesia
2.0
7.1
88
467
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.1
7.0
85
446
SPAT1240
SPAT
Therapeutic discussion
2.0
7.0
85
447
C03CA01
ATC
furosemide; systemic
2.1
7.0
76
380
N06AA12
ATC
doxepin; systemic
3.9
6.9
27
72
K90
ICPC
Stroke/cerebrovascular accident
7.7
6.9
15
20
RT130
NOMESCO Finland
NA
14.0
6.9
11
8
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.6
6.8
50
205
M79.6
ICD-10 Finland
Pain in limb
1.7
6.8
173
1163
NEK20
NOMESCO Finland
Fenestration or forage of bone of pelvis
40.5
6.8
8
*
NH1EA
NOMESCO Finland
Ankle X-ray examination with load or wrench
16.9
6.8
10
6
SPAT1293
SPAT
Other function in accordance with rehabilitation guidance nomenclature
22.8
6.7
9
*
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.9
6.6
92
510
CEC10
NOMESCO Finland
Recession and resection of extraocular muscle
7.0
6.5
15
22
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.7
6.5
43
169
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.4
6.5
52
227
H52.0
ICD-10 Finland
Hypermetropia
3.8
6.4
25
67
UKC02
NOMESCO Finland
Cystoscopy
2.3
6.4
59
273
SPAT1153
SPAT
Removal of sutures
1.8
6.4
127
793
R51
NOMESCO Finland
Aids services
70.6
6.4
7
*
H35.1
ICD-10 Finland
Retinopathy of prematurity
70.6
6.4
7
*
Q03.9
ICD-10 Finland
Congenital hydrocephalus, unspecified
70.6
6.4
7
*
G40.0
ICD-10 Finland
Localization-related (focal)(partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset
70.6
6.4
7
*
P27.1
ICD-10 Finland
Bronchopulmonary dysplasia originating in the perinatal period
70.6
6.4
7
*
N05AA02
ATC
levomepromazine; systemic
3.5
6.4
28
83
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
3.2
6.4
31
100
WX725
NOMESCO Finland
Noninvasive ventilation
3.4
6.4
29
89
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
2.9
6.3
36
127
U07.2
ICD-10 Finland
COVID-19, virus not identified
0.5
6.3
53
978
AEA50
NOMESCO Finland
Adjustment of implanted neurostimulator
11.2
6.3
11
10
N31.0
ICD-10 Finland
Uninhibited neuropathic bladder, not elsewhere classified
18.2
6.3
9
5
M67.0
ICD-10 Finland
Short Achilles tendon (acquired)
18.2
6.3
9
5
ADB00
NOMESCO Finland
Implantation of vagus nerve stimulating device
18.2
6.3
9
5
31599
ICD-8 Finland
Unspecified mental retardation, Other and unspecified
+∞
6.3
6
*
RK321
NOMESCO Finland
NA
+∞
6.3
6
*
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
3.7
6.3
25
69
J45.9
ICD-10 Finland
Asthma, unspecified
1.9
6.2
94
534
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
3.9
6.2
24
64
3159X
ICD-9 Finland
Specific delays in development, Unspecified delay in development
27.0
6.2
8
*
XF400
NOMESCO Finland
ECG with 12 standard connections
2.0
6.2
81
435
S17
ICPC
Abrasion/scratch/blister
3.6
6.2
26
75
TNH32
NOMESCO Finland
Custom moulded split, ankle or foot
10.2
6.0
11
11
O80.0
ICD-10 Finland
Spontaneous vertex delivery
0.5
6.0
54
978
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
6.0
109
658
TNH33
NOMESCO Finland
Custom moulded brace, ankle or foot
5.6
6.0
16
29
K05.18
ICD-10 Finland
Chronic gingivitis
2.6
6.0
42
168
G04BD12
ATC
mirabegron; oral
2.9
6.0
35
127
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3023368) Bacteria identified in Blood by Culture
197
969
2.47
23.10
4.6
4.0
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
204
1090
2.26
19.29
4.6
2.4
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
240
1379
2.16
18.87
7.2
6.3
inr
1.2
1.1
0.37
62
433
(3024561) Albumin [Mass/volume] in Serum or Plasma
276
1674
2.12
18.84
7.0
5.8
g/l
35.6
37.3
4.57
256
1582
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
301
1898
2.08
18.41
13.7
8.3
mmol/l
1.2
1.2
1.11
280
1771
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
252
1526
2.05
16.85
5.2
3.3
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
315
2079
1.99
16.40
12.7
8.2
mmol/l
1.2
1.2
0.70
278
1818
(3003396) Base excess in Arterial blood by calculation
92
370
2.73
15.91
7.7
11.0
mmol/l
0.9
0.8
0.07
72
293
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
197
1133
2.05
14.83
3.5
2.1
u/l
234.0
268.0
0.19
190
1079
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
90
372
2.64
14.71
7.8
10.9
kpa
5.1
5.2
0.27
84
351
(3027801) Oxygen [Partial pressure] in Arterial blood
90
372
2.64
14.71
7.8
10.9
kpa
14.0
13.3
0.43
84
353
(3013826) Glucose [Moles/volume] in Serum or Plasma
370
2643
1.91
14.64
7.9
5.6
mmol/l
6.3
6.4
0.07
349
2411
(3016502) Oxygen saturation in Arterial blood
82
329
2.70
14.20
7.9
12.0
%
96.6
96.0
0.39
77
315
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
17
19
9.16
13.82
2.9
2.5
umol/l
34.2
31.1
0.58
12
14
(3012095) Magnesium [Moles/volume] in Serum or Plasma
130
664
2.19
13.19
5.6
5.7
mmol/l
0.8
0.8
0.65
120
632
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
17
21
8.28
12.80
2.1
2.1
umol/l
23.1
17.2
0.87
17
21
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
211
1303
1.91
12.62
3.0
2.6
u/l
53.9
55.7
0.30
192
1223
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
121
613
2.19
12.48
2.6
1.9
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
159
894
2.03
12.47
4.0
2.7
e6/l
8.1
7.2
0.25
144
781
(3019550) Sodium [Moles/volume] in Serum or Plasma
578
4972
2.32
11.70
22.9
11.5
mmol/l
139.4
139.6
0.68
568
4843
(3002582) Erythrocytes [#/volume] in Urine
213
1348
1.86
11.64
5.2
3.3
e6/l
42.3
49.6
0.14
172
1007
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
99
478
2.26
11.44
18.5
7.2
kpa
5.1
5.1
0.30
93
448
(3023103) Potassium [Moles/volume] in Serum or Plasma
578
4985
2.30
11.41
22.6
11.6
mmol/l
3.9
3.9
0.03
566
4833
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
307
2182
1.76
11.29
5.7
6.4
umol/l
11.1
14.1
1.95
283
2066
(3042936) Bacteria identified in Isolate by Culture
113
583
2.13
11.06
2.3
2.0
—
—
—
0
0
(3009343) pH of Capillary blood
98
479
2.23
10.98
18.8
7.2
ph
7.4
7.4
—
6
26
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
82
375
2.36
10.73
2.7
4.6
u/l
352.6
272.5
0.45
77
362
(3022313) Gas panel - Capillary blood
84
389
2.33
10.68
15.8
7.3
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
194
1224
1.83
10.54
4.8
3.1
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
193
1218
1.83
10.47
4.9
3.2
e6/l
0.4
0.3
0.14
151
889
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
95
469
2.20
10.37
19.2
7.3
mmol/l
1.4
1.1
0.28
70
331
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
88
421
2.26
10.36
2.4
1.8
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
52
195
2.81
10.21
8.7
15.5
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
178
1108
1.83
10.04
2.6
2.5
mg/l
2.9
2.8
0.08
152
969
(3044640) Blood type and Crossmatch panel - Blood
213
1401
1.77
9.98
3.0
2.3
—
—
—
0
0
(3026782) Osmolality of Urine
146
858
1.90
9.85
4.0
2.6
mosm/kgh2o
584.6
574.2
0.19
128
735
(3007853) Bacteria identified in Skin by Aerobe culture
113
609
2.03
9.79
2.6
1.5
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
389
3034
1.69
9.60
7.3
3.7
e6/l
3960.6
1501.7
0.39
13
41
(3002032) Base excess in Venous blood by calculation
103
541
2.07
9.56
7.5
7.6
mmol/l
1.3
1.4
0.04
87
415
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
87
428
2.19
9.56
2.7
1.9
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
22
49
4.61
9.36
3.9
1.2
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
13
17
7.78
9.30
3.8
2.5
umol/l
1.1
1.1
0.00
13
17
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
64
279
2.43
9.30
2.4
1.7
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
125
713
1.93
9.18
4.5
3.0
ng/l
158.4
582.1
1.55
84
446
(3014111) Lactate [Moles/volume] in Serum or Plasma
80
389
2.20
9.04
8.3
10.5
mmol/l
1.3
1.3
0.02
75
364
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
17
31
5.60
9.01
3.1
1.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
96
506
2.05
8.80
10.9
10.9
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
171
1091
1.77
8.73
2.9
2.3
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
423
3431
1.65
8.46
8.2
6.7
u/l
89.4
84.2
0.94
396
3246
(3022948) Iron [Moles/volume] in Serum or Plasma
114
649
1.91
8.38
3.3
2.5
umol/l
13.3
14.5
0.87
106
607
(3004789) Transferrin [Mass/volume] in Serum or Plasma
106
593
1.94
8.20
3.2
2.5
g/l
2.5
2.5
0.15
98
557
(21494755) Public health laboratory ask at order entry panel
31
812
0.35
8.06
1.2
1.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
122
719
1.86
8.04
4.3
3.0
e6/l
4.7
2.4
1.04
58
366
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
286
2126
1.61
8.03
4.3
3.9
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
35
121
3.00
7.97
16.5
4.9
mmol/l
24.1
23.9
0.07
30
107
(3052851) Hemolysis interference index of Serum or Plasma
36
127
2.94
7.92
3.0
2.6
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
21
52
4.14
7.85
1.1
1.3
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
232
1654
1.62
7.65
6.5
3.8
e6/l
103.8
95.9
0.06
178
1079
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
79
408
2.06
7.63
6.5
7.7
mmol/l
24.0
23.7
0.39
74
387
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
123
738
1.82
7.63
4.1
2.9
e6/l
1.1
0.8
0.96
60
388
(3013336) Amino acids [Identifier] in Serum or Plasma
12
18
6.77
7.63
2.5
2.9
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
34
121
2.91
7.38
2.9
2.2
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
96
539
1.91
7.32
3.5
2.7
%
21.4
23.7
0.79
80
480
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
75
388
2.05
7.21
18.0
7.4
mmol/l
24.2
24.3
0.08
75
382
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
233
1691
1.58
7.00
4.0
3.6
u/l
43.6
32.1
0.65
221
1616
(3023520) Reticulocytes [#/volume] in Blood
61
296
2.17
6.93
3.5
3.8
e9/l
64.2
71.4
0.93
48
208
(3016018) Differential panel - Cerebral spinal fluid
22
63
3.58
6.76
3.0
2.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
166
1118
1.65
6.75
4.6
3.9
ph
7.4
7.4
1.49
32
187
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
52
239
2.28
6.73
1.4
1.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
45
194
2.42
6.73
6.4
6.9
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
93
532
1.87
6.69
1.7
1.6
nmol/l
1067.6
1144.5
0.36
70
421
(3015377) Calcium [Moles/volume] in Serum or Plasma
190
1326
1.61
6.68
2.9
2.9
mmol/l
2.3
2.4
0.93
169
1207
(3027945) Reticulocytes/100 erythrocytes in Blood
80
439
1.94
6.52
3.7
4.6
%
1.6
1.6
0.06
72
409
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
19
51
3.81
6.40
8.1
5.7
mg/l
11.3
10.2
0.38
19
46
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
50
231
2.26
6.40
2.9
2.7
ng/l
138.5
135.0
0.02
44
206
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
32
121
2.73
6.24
1.9
2.8
g/l
1.2
1.2
0.06
27
105
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
83
1369
0.55
6.13
1.9
2.3
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
19
54
3.59
5.92
3.0
1.4
promille
1.2
1.4
0.27
13
41
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
71
389
1.92
5.81
7.4
5.9
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
43
196
2.28
5.70
2.8
1.7
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
75
1246
0.55
5.63
1.8
2.1
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
20
61
3.35
5.62
8.3
2.9
mmol/l
87.1
69.4
0.56
20
51
(42870588) Differential panel, method unspecified - Blood
241
1832
1.50
5.60
8.7
6.8
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
121
788
1.66
5.52
1.7
1.4
nmol/l
23.8
20.4
1.14
104
691
(3037467) Urinalysis macro (dipstick) panel - Urine
397
3341
1.47
5.44
6.3
3.8
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
32
133
2.48
5.21
2.8
2.1
e6/l
982.6
153.5
0.47
23
97
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
32
133
2.48
5.21
2.7
2.1
e6/l
43.1
7.6
0.45
22
91
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
114
751
1.63
4.95
3.1
3.5
ng/l
1291.5
777.4
0.30
90
616
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
249
1942
1.45
4.94
3.6
2.6
nmol/l
72.8
71.6
0.26
230
1821
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
66
373
1.86
4.93
3.8
2.6
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
92
574
1.70
4.92
1.9
2.4
mmol/l
2.4
2.4
1.84
74
493
(3021901) Oxygen saturation in Capillary blood
21
72
2.98
4.91
7.4
3.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
12
380
0.30
4.53
1.8
1.5
—
—
—
0
0
(3020891) Body temperature
31
136
2.34
4.52
12.6
6.5
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
44
228
2.00
4.26
6.9
7.6
g/l
130.7
130.1
0.06
44
223
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
24
96
2.56
4.26
1.2
2.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
123
1704
0.66
4.21
2.1
2.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
33
650
0.48
4.20
1.5
1.5
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
26
109
2.44
4.19
1.6
1.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
21
79
2.71
4.19
2.4
2.7
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
56
318
1.83
4.15
18.9
15.6
inr
1.5
1.2
0.44
12
55
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
188
1432
1.44
4.10
2.2
1.7
pmol/l
84.7
95.9
3.45
112
787
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
104
702
1.57
4.07
1.6
1.6
pmol/l
170588686.0
11022790.9
0.45
85
626
(3014271) Vancomycin [Susceptibility]
8
10
8.08
4.07
3.4
2.0
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
86
556
1.63
4.02
3.0
4.3
umol/l
5.9
7.4
0.61
65
467
(3032641) Amino acids panel - Urine
7
7
10.09
4.02
1.0
1.4
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
295
2443
1.38
3.91
3.4
2.9
ug/l
299.6
84.7
0.61
266
2317
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
73
1116
0.61
3.87
1.6
1.6
—
—
—
0
0
(40758558) Short blood count panel - Blood
180
1375
1.43
3.83
8.4
6.8
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
144
1057
1.46
3.79
2.9
2.3
mg/l
3.2
1.1
1.38
114
751
(3013115) Eosinophils [#/volume] in Blood
329
2793
1.36
3.64
9.4
7.1
e9/l
0.2
0.2
0.01
295
2486
(40767503) Oxygen content in Capillary blood by calculation
18
68
2.69
3.59
4.2
2.6
%
15.9
17.6
1.06
11
34
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
11
31
3.59
3.49
2.0
1.5
—
—
—
0
0
(44790049)
20
82
2.48
3.41
2.2
1.8
—
—
—
0
0
(44790048)
20
82
2.48
3.41
2.2
1.8
—
—
—
0
0
(44806118)
20
82
2.48
3.41
2.2
1.8
—
—
—
0
0
(44790047)
20
82
2.48
3.41
2.2
1.8
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
41
227
1.86
3.32
2.4
2.2
ug/l
8.2
7.8
0.06
32
208
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
22
459
0.46
3.31
1.3
1.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
150
1929
0.71
3.30
2.2
2.3
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
317
2704
1.33
3.28
9.1
6.7
e9/l
0.6
0.6
1.20
281
2366
(3012501) Base excess in Blood by calculation
20
84
2.42
3.25
6.4
5.2
mmol/l
1.8
2.4
0.58
12
51
(1002224) Polysomnography panel
9
249
0.35
3.24
1.0
1.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
19
78
2.48
3.24
2.4
1.6
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
168
1305
1.39
3.19
3.4
2.9
ng/l
24.0
44.8
0.76
116
658
(3006315) Basophils [#/volume] in Blood
317
2712
1.33
3.18
9.1
6.7
e9/l
0.0
0.0
0.36
281
2378
(3006184) Hemoglobin [Mass/volume] in Capillary blood
20
85
2.40
3.18
2.9
2.7
g/l
127.5
132.2
0.30
15
66
(3022096) Basophils/100 leukocytes in Blood
293
2487
1.32
3.08
9.2
6.9
%
0.6
0.7
0.62
274
2367
(3019069) Monocytes/100 leukocytes in Blood
302
2576
1.32
3.06
10.0
7.0
%
8.4
8.2
0.33
286
2458
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
137
1770
0.71
3.06
1.8
1.7
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
77
519
1.55
3.04
1.6
1.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
14
51
2.78
3.00
2.1
1.7
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
282
2388
1.32
2.99
5.1
3.0
estimate
0.0
0.0
0.50
54
431
(3013650) Neutrophils [#/volume] in Blood by Automated count
350
3054
1.31
2.98
12.9
9.1
e9/l
4.1
3.9
1.03
310
2663
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
5
5
10.06
2.98
6.0
13.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
9
241
0.36
2.98
1.3
1.5
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
16
63
2.58
2.97
2.1
1.7
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
37
207
1.83
2.93
5.0
2.8
e6/l
0.1
0.1
0.31
37
199
(3005033) Fetal Nuchal fold Thickness US
9
235
0.37
2.85
1.1
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
9
237
0.37
2.85
1.2
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
433
4724
0.76
2.84
3.5
3.7
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
15
59
2.58
2.80
2.7
1.7
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
72
1031
0.66
2.80
1.6
1.8
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
26
131
2.03
2.79
2.7
1.8
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
298
2561
1.30
2.78
9.5
6.8
%
2.8
2.9
0.36
282
2433
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
17
72
2.40
2.74
2.5
1.6
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
21
98
2.18
2.73
1.6
1.3
—
—
—
0
0
(3049233) Organic acids panel - Urine
7
14
5.04
2.73
1.6
1.0
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
324
2822
1.29
2.70
9.7
6.7
e9/l
2.1
2.1
0.03
291
2519
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
11
37
3.01
2.70
1.8
1.8
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
11
37
3.01
2.70
1.8
1.8
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
11
37
3.01
2.70
1.8
1.8
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
281
2405
1.29
2.67
5.2
3.1
estimate
0.0
0.0
0.00
57
423
(3021601) Nitrite [Presence] in Urine by Test strip
278
2378
1.29
2.65
6.7
4.3
estimate
0.0
0.0
0.50
55
451
(3029937) Albumin [Presence] in Urine by Test strip
153
1204
1.35
2.64
6.2
3.3
estimate
0.0
0.0
1.08
55
434
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
61
890
0.65
2.60
1.4
1.5
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
8
20
4.04
2.57
1.4
1.6
nmol/l
2.0
0.9
—
8
15
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
20
94
2.16
2.57
2.2
1.8
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
52
782
0.64
2.55
1.6
2.1
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
64
432
1.53
2.54
2.4
2.4
u/l
30.1
145.5
0.52
50
364
(3011397) Hemoglobin [Presence] in Urine by Test strip
141
1103
1.35
2.53
5.0
3.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
11
39
2.85
2.48
1.8
2.9
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
11
39
2.85
2.48
6.5
4.0
umol/l
22.3
26.6
0.95
11
39
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
39
623
0.60
2.47
1.5
2.0
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
115
874
1.38
2.47
3.6
3.5
mg/l
62.4
306.7
1.22
84
580
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
15
320
0.46
2.44
1.5
1.5
—
—
—
0
0
(3019225) pH of Specimen
49
315
1.60
2.40
6.2
4.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
159
1276
1.32
2.39
3.9
3.7
mmol/l
7.5
8.7
2.02
138
1125
(3025468) Yersinia sp identified in Specimen by Organism specific culture
13
52
2.53
2.37
1.8
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
8
22
3.67
2.37
1.5
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
8
22
3.67
2.37
1.5
1.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
24
431
0.54
2.35
2.9
2.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
118
910
1.36
2.31
4.0
4.3
mg/mmol
11.2
11.9
0.06
76
607
(4198724)
14
59
2.40
2.30
1.3
2.0
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
25
134
1.90
2.29
2.6
1.8
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
30
502
0.58
2.29
2.6
2.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
13
53
2.48
2.29
1.8
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
13
53
2.48
2.29
1.8
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
13
53
2.48
2.29
1.8
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
33
534
0.60
2.22
2.5
2.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
54
2.44
2.21
1.7
1.6
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
34
545
0.60
2.20
2.5
2.2
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
14
293
0.47
2.19
1.4
1.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
44
283
1.59
2.17
4.2
3.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
34
543
0.61
2.17
2.5
2.2
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
14
292
0.47
2.17
1.4
1.4
—
—
—
0
0
(3011048) Pyruvate [Moles/volume] in Blood
6
14
4.31
2.15
1.5
1.6
umol/l
81.7
89.9
—
6
14
(3018010) Neutrophils/100 leukocytes in Blood
303
2668
1.25
2.15
9.2
6.5
%
53.7
54.4
0.40
285
2553
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
14
291
0.47
2.15
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
14
291
0.47
2.15
1.4
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
34
541
0.61
2.14
2.5
2.2
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
306
2699
1.25
2.13
9.6
6.7
%
31.1
31.2
0.07
289
2580
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
19
96
2.01
2.07
2.0
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
19
96
2.01
2.07
2.0
1.3
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
56
0.00
2.07
0.0
1.8
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
35
548
0.62
2.07
1.5
1.5
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
428
3928
1.26
2.07
4.4
3.8
pmol/l
14.6
14.5
0.47
383
3655
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
27
155
1.77
2.03
2.1
2.0
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
20
104
1.95
2.02
2.5
1.5
—
—
—
0
0
(3013512) EKG study
118
931
1.33
1.99
3.3
3.0
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
25
141
1.80
1.99
2.2
1.9
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
556
5281
1.34
1.99
21.1
10.6
mg/l
25.7
21.1
2.48
459
3957
(43055514) Macroprolactin [Presence] in Serum or Plasma
7
21
3.36
1.97
2.4
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
12
51
2.38
1.96
1.9
1.4
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
5
11
4.57
1.94
1.0
1.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
134
1081
1.30
1.93
5.1
3.1
kg/l
1.0
1.0
0.04
18
156
(3021879) Hepatitis B virus core Ab [Presence] in Serum
39
582
0.65
1.88
1.6
1.5
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
22
377
0.57
1.87
3.1
3.3
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
53
369
1.47
1.87
4.1
5.0
%
0.5
0.7
0.43
17
113
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
6
17
3.55
1.84
3.3
3.1
ug/l
192.5
165.4
—
6
17
(3024522) Salmonella sp identified in Specimen by Organism specific culture
12
53
2.29
1.81
1.9
1.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
17
87
1.98
1.81
6.0
3.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
16
80
2.02
1.81
2.1
1.6
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
491
4607
1.26
1.81
5.1
4.3
mu/l
4.4
2.1
0.44
442
4352
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
7
23
3.06
1.80
5.9
6.7
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
18
95
1.92
1.77
1.2
1.3
u/ml
5.3
4.1
0.15
13
46
(3045788) Cell count panel - Pleural fluid
6
18
3.35
1.75
1.7
1.4
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
9
36
2.52
1.74
2.3
2.0
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
11
48
2.31
1.71
2.0
2.9
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
18
97
1.88
1.67
2.9
9.8
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
6
19
3.18
1.66
1.0
1.0
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
6
19
3.18
1.66
1.7
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
6
19
3.18
1.66
1.7
1.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
14
69
2.05
1.65
9.4
3.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
14
69
2.05
1.65
2.0
1.4
—
—
—
0
0
(3022670) pH of Venous cord blood
5
14
3.59
1.62
1.0
1.0
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
22
360
0.60
1.60
1.5
1.4
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
7
26
2.71
1.58
5.6
2.9
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
17
92
1.87
1.57
2.7
2.4
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
5
15
3.35
1.52
1.8
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
13
65
2.02
1.49
1.5
3.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
17
94
1.83
1.48
5.2
7.1
u/ml
0.3
0.3
—
10
55
(3006922) Hepatitis E virus Ab [Presence] in Serum
9
38
2.39
1.46
1.1
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
440
4663
0.83
1.44
3.8
3.4
mmol/l
1.4
1.4
1.07
407
4423
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
9
39
2.33
1.43
1.2
1.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
565
5435
1.28
1.41
12.0
8.6
u/l
30.3
28.2
0.71
547
5302
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
10
46
2.19
1.40
1.2
1.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
71
901
0.76
1.36
2.1
1.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
42
577
0.71
1.36
1.8
1.9
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
507
5292
0.82
1.35
22.4
11.9
%
40.1
40.7
0.95
336
4506
(3000570) Elastase.pancreatic [Mass/mass] in Stool
21
128
1.66
1.34
1.5
1.3
ug/g
311.6
348.6
0.43
14
74
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
10
194
0.51
1.33
1.1
1.3
—
—
—
0
0
(4010399)
40
284
1.43
1.33
1.4
1.4
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
46
336
1.40
1.31
4.3
4.8
%
0.2
0.4
—
10
78
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
112
1337
0.80
1.31
2.0
1.7
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
6
133
0.45
1.29
1.3
1.1
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
18
2.79
1.28
1.6
1.8
—
—
—
0
0
(3008898) HLA-B27 [Presence]
20
311
0.63
1.22
1.1
1.1
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
5
19
2.64
1.22
2.2
2.1
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
5
19
2.64
1.22
2.2
2.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
5
19
2.64
1.22
2.2
2.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
5
19
2.64
1.22
2.2
2.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
8
37
2.18
1.21
1.1
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
8
37
2.18
1.21
1.1
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
37
2.18
1.21
1.5
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
8
39
2.06
1.15
1.4
2.0
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
102
854
1.23
1.11
2.7
2.8
ug/g
229.6
116.0
0.77
85
679
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
7
31
2.27
1.10
1.4
2.0
%
115.9
126.1
—
7
31
(40761536) Microorganisms panel - Urine sediment
53
409
1.32
1.10
6.3
3.2
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
32
2.20
1.08
1.7
1.0
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
32
2.20
1.08
1.6
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
7
32
2.20
1.08
1.0
1.2
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
16
97
1.67
1.07
2.8
3.8
mg/l
9.7
23.9
3.78
11
66
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
23
336
0.67
1.07
1.5
1.9
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
10
52
1.94
1.06
7.1
9.8
mmol/l
0.7
0.6
—
10
47
(3008401) Mugwort IgE Ab [Units/volume] in Serum
13
215
0.60
1.04
1.2
1.2
u/ml
0.4
1.6
—
7
133
(3035637) Corticotropin [Mass/volume] in Plasma
16
98
1.65
1.04
2.3
1.6
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
10
53
1.90
1.01
2.8
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
18
273
0.65
1.01
1.5
1.4
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
7
35
2.01
1.00
2.4
1.9
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
39
511
0.75
0.98
1.9
2.5
ug/l
0.9
0.8
0.18
21
260
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
15
92
1.65
0.98
1.3
1.3
u/ml
10.1
6.3
—
7
38
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
31
0.00
0.96
0.0
2.7
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
45
348
1.31
0.95
4.5
5.2
%
0.0
0.1
2.15
13
101
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
16
101
1.60
0.94
2.1
1.3
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
27
192
1.42
0.94
6.1
5.9
g/l
0.3
0.4
0.32
19
119
(3017732) Neutrophils [#/volume] in Blood
46
358
1.31
0.93
4.3
2.2
e9/l
4.0
4.0
0.01
33
318
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
54
430
1.28
0.92
4.0
3.3
%
30.5
30.5
0.01
36
309
(3003888) Timothy IgE Ab [Units/volume] in Serum
14
219
0.63
0.91
1.1
1.2
u/ml
11.3
6.0
—
9
147
(3013707) Erythrocyte sedimentation rate by Westergren method
375
3537
1.14
0.91
4.3
3.7
mm/h
11.3
8.8
2.89
348
3316
(3021589) Normoblasts [#/volume] in Blood
262
2417
1.14
0.89
11.4
8.7
e9/l
0.0
0.0
0.17
217
1950
(3037756) Immunofixation for Serum or Plasma
8
42
1.92
0.89
1.0
1.6
—
—
—
0
0
(3000492) Spirometry study
41
523
0.77
0.87
1.6
1.4
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
18
120
1.51
0.86
6.0
3.7
nmol/l
26.7
23.6
0.40
18
115
(3025159) Blasts/100 leukocytes in Blood
43
336
1.30
0.85
4.6
5.2
%
0.0
0.1
0.57
12
87
(3004716) Salmonella sp identified in Stool by Organism specific culture
29
386
0.74
0.83
1.4
1.3
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
6
32
1.88
0.82
1.0
3.6
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
6
32
1.88
0.82
1.0
1.2
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
6
32
1.88
0.82
1.0
3.6
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
6
32
1.88
0.82
9.8
2.1
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
43
339
1.29
0.81
2.1
1.6
mu/l
547.6
312.0
1.34
38
305
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
8
48
1.67
0.79
1.3
2.0
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
12
74
1.63
0.78
2.5
2.2
ug/min
8.7
122.3
—
7
44
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
16
233
0.68
0.77
1.1
1.2
u/ml
3.5
1.8
0.31
11
131
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
454
4360
1.13
0.77
14.1
8.8
ml/min/173m2
102.2
94.8
7.30
347
3430
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
197
1800
1.13
0.77
5.5
3.0
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
129
1145
1.16
0.76
1.6
1.7
mmol/l
1.5
1.4
0.93
115
1015
(4268621)
11
67
1.65
0.75
2.5
2.4
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
7
39
1.80
0.72
2.6
4.0
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
36
454
0.78
0.72
1.3
1.3
iu/ml
77.5
164.5
1.61
19
173
(3004588) Protein electrophoresis panel - Serum or Plasma
20
143
1.41
0.71
2.4
2.3
—
—
—
0
0
(4146454)
5
26
1.93
0.70
2.2
3.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
9
58
1.56
0.70
1.0
1.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
14
93
1.52
0.70
5.6
4.3
%
54.6
55.1
0.05
14
93
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
455
4711
0.89
0.69
4.1
3.7
mmol/l
2.9
2.9
0.19
415
4448
(3024932) HLA-DR beta [Type]
5
27
1.86
0.68
1.2
1.1
—
—
—
0
0
(4027681)
7
42
1.67
0.68
1.4
1.2
—
—
—
0
0
(4094501)
5
91
0.55
0.67
1.4
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
7
43
1.63
0.67
2.1
1.5
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
7
43
1.63
0.67
1.1
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
5
28
1.79
0.66
1.0
1.0
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
10
62
1.62
0.65
2.2
3.0
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
5
29
1.73
0.64
1.0
1.3
—
—
—
0
0
(4306422)
13
87
1.50
0.63
1.1
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
22
165
1.34
0.61
2.1
1.8
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
28
218
1.30
0.61
1.6
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
17
232
0.73
0.60
1.6
1.7
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
20
0.00
0.60
0.0
1.8
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
22
0.00
0.59
0.0
3.8
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
22
0.00
0.59
0.0
1.8
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
566
5546
1.15
0.57
18.8
9.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
6
36
1.67
0.57
2.0
4.7
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
6
36
1.67
0.57
1.2
2.5
ug/l
21.7
19.8
—
6
36
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
11
73
1.52
0.56
2.3
1.6
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
11
73
1.52
0.56
2.7
2.8
—
43.2
—
0
6
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
8
55
1.46
0.56
1.1
4.1
—
3.3
—
0
8
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
5
90
0.55
0.56
2.2
1.9
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
6
38
1.58
0.54
1.0
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
20
260
0.76
0.53
1.8
4.5
ug/l
10.2
9.1
—
9
205
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
9
63
1.43
0.52
2.1
1.3
—
—
—
0
0
(4062490)
9
63
1.43
0.52
1.7
1.3
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
6
96
0.62
0.52
1.2
1.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
455
4414
1.10
0.52
4.3
3.3
mmol/l
5.9
5.7
1.68
412
4109
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
33
401
0.81
0.52
1.0
1.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
18
236
0.76
0.51
2.4
1.8
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
169
1568
1.10
0.51
1.2
1.4
u/ml
1.5
1.9
0.26
37
381
(3003694) ABO and Rh group [Type] in Blood
178
1656
1.10
0.51
1.4
1.6
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
417
4035
1.09
0.49
5.6
4.2
mmol/mol
38.3
38.0
0.25
381
3846
(3030905) Polymorphonuclear cells [#/volume] in Blood
13
93
1.41
0.48
4.2
4.0
e9/l
3.6
4.0
0.36
13
93
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
7
46
1.53
0.48
1.1
1.1
mg/l
208.0
252.1
—
7
39
(3010726) Horse dander IgE Ab [Units/volume] in Serum
16
210
0.76
0.47
1.1
1.2
u/ml
0.1
3.6
—
6
63
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
5
82
0.61
0.46
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
13
175
0.74
0.45
1.2
1.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
10
69
1.46
0.44
2.1
1.5
e6/l
6600.4
9858.8
—
5
48
(3028707) Methadone [Presence] in Urine by Screen method
20
252
0.79
0.44
2.8
3.0
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
13
174
0.74
0.44
1.2
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
14
185
0.75
0.43
1.4
1.7
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
5
33
1.52
0.41
1.6
1.6
pg
34.2
31.8
—
5
33
(3010838) Calcium [Moles/time] in 24 hour Urine
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
8
59
1.36
0.41
1.1
1.1
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
8
59
1.36
0.41
1.0
1.2
mu/l
21.9
51.1
—
8
52
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
15
114
1.32
0.41
1.5
1.1
iu/ml
172.5
186.3
—
7
35
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
22
270
0.81
0.40
1.5
1.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
146
1363
1.09
0.40
4.8
2.6
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
13
97
1.35
0.39
1.1
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
16
204
0.78
0.39
1.4
1.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
18
142
1.28
0.39
1.2
1.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
96
880
1.11
0.38
2.6
3.5
ug/l
10.3
2.2
0.43
82
809
(3022621) pH of Urine by Test strip
31
262
1.19
0.37
2.7
2.2
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
482
4718
1.08
0.37
24.3
13.5
%
13.7
13.3
3.94
471
4649
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
9
69
1.31
0.37
1.1
1.5
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
46
403
1.15
0.37
3.4
2.4
u/l
1092.5
3957.8
1.59
13
167
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
458
4681
0.93
0.36
3.9
3.5
mmol/l
4.6
4.7
1.12
420
4454
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
9
71
1.27
0.36
1.3
1.7
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
9
122
0.73
0.35
2.0
1.5
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
9
123
0.73
0.35
2.6
2.1
mg/l
10.8
9.8
—
9
112
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
436
4461
0.93
0.35
3.5
3.2
mmol/l
1.4
1.3
1.31
395
4234
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
15
189
0.79
0.35
1.5
1.3
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
6
45
1.34
0.34
1.7
1.4
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
6
88
0.68
0.33
1.2
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
60
542
1.12
0.32
1.4
1.3
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
15
119
1.27
0.32
1.1
1.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
23
193
1.20
0.31
2.1
1.6
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
10
75
1.34
0.30
1.0
1.1
g/l
1.5
1.4
—
10
67
(3009214) Lutropin [Units/volume] in Serum or Plasma
34
297
1.15
0.30
2.5
1.7
u/l
4.5
7.6
2.44
25
228
(3014133) Dog dander IgE Ab [Units/volume] in Serum
12
152
0.79
0.29
1.0
1.1
u/ml
1.7
5.9
—
7
72
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
7
57
1.23
0.29
1.1
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
14
112
1.26
0.28
1.1
1.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
74
801
0.91
0.28
1.3
1.2
iu/ml
17.5
25.5
0.56
13
243
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
8
62
1.29
0.28
1.9
2.5
—
750.4
—
0
21
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
8
63
1.27
0.28
1.9
1.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
42
468
0.89
0.27
1.4
1.4
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
8
66
1.21
0.27
1.4
1.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
5
71
0.70
0.26
1.2
1.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
71
766
0.92
0.25
1.3
1.2
u/ml
8.3
10.8
0.13
21
318
(3023323) Follitropin [Units/volume] in Serum or Plasma
42
380
1.11
0.23
2.3
1.5
iu/l
18.5
19.8
0.09
32
305
(3047007) Chlamydophila sp Ab [Presence] in Serum
10
125
0.80
0.23
1.2
1.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
5
39
1.28
0.23
1.2
5.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
35
314
1.12
0.22
1.4
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
13
157
0.82
0.22
1.6
1.5
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
7
95
0.73
0.22
1.4
1.2
—
—
—
0
0
(42870560) Thyrotropin [Units/volume] in Cord blood
10
79
1.27
0.22
1.0
1.0
mu/l
13.3
9.4
—
10
67
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
42
1.19
0.21
1.0
1.1
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
11
0.00
0.21
0.0
2.1
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(4133840)
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
5.8
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
12
0.00
0.21
0.0
7.3
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
8
105
0.76
0.21
1.0
1.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
164
1704
0.95
0.21
1.8
1.9
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
6
49
1.23
0.20
1.2
1.5
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
6
51
1.18
0.19
2.3
2.0
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
25
222
1.13
0.19
1.8
1.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
6
53
1.13
0.18
2.5
13.7
%
11.1
12.3
—
6
53
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
14
164
0.85
0.18
1.4
2.2
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
610
6063
1.08
0.18
29.1
15.6
e9/l
265.5
258.8
1.63
594
5919
(3016650) Hepatitis A virus Ab [Presence] in Serum
10
121
0.82
0.18
1.0
1.1
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
7
62
1.13
0.17
1.1
1.3
—
208.2
—
0
11
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
21
186
1.13
0.17
2.2
1.6
u/ml
203.8
209.6
0.04
12
96
(3006598) pH of Arterial cord blood
8
70
1.14
0.16
1.0
1.0
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
15
172
0.87
0.16
1.5
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
8
73
1.10
0.15
2.4
1.3
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
14
161
0.87
0.15
1.8
2.0
pmol/l
228.7
224.5
0.04
14
154
(1761482) Bacteria [#/volume] in Urine by Culture
9
80
1.13
0.15
4.0
3.2
—
—
—
0
0
(3024731) MCV [Entitic volume]
610
6069
1.07
0.14
28.7
15.6
fl
88.7
89.1
1.31
604
6014
(3045424) Erythrocytes [Presence] in Urine
10
84
1.19
0.14
1.7
1.4
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
15
170
0.88
0.14
1.5
1.2
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
15
170
0.88
0.14
1.3
1.7
—
288.0
—
0
5
(3035941) MCH [Entitic mass]
610
6070
1.07
0.13
28.7
15.5
pg
29.6
29.9
3.20
604
6014
(3026361) Erythrocytes [#/volume] in Blood
610
6071
1.06
0.13
28.8
15.6
e12/l
4.6
4.6
0.27
593
5918
(3014765) Yersinia sp identified in Stool by Organism specific culture
15
169
0.88
0.13
1.5
1.2
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
12
137
0.87
0.12
1.0
1.1
u/ml
1.1
5.3
—
7
66
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
28
302
0.92
0.11
2.5
2.6
ml/min/173m2
76.9
78.5
0.04
11
116
(3049717) Cytology report of Urine Cyto stain
10
86
1.17
0.11
1.5
2.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
20
218
0.91
0.10
1.1
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
15
166
0.90
0.10
4.2
2.5
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
610
6077
1.05
0.09
28.8
15.6
e9/l
7.0
6.7
2.68
594
5916
(3000963) Hemoglobin [Mass/volume] in Blood
610
6077
1.05
0.09
29.2
15.8
g/l
135.7
137.8
2.59
605
6016
(3000093) Morphology [Interpretation] in Blood Narrative
5
48
1.04
0.09
2.6
1.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
84
867
0.96
0.09
3.0
1.8
%
1.5
1.4
0.37
74
800
(3044889) 12 lead EKG panel
287
2906
0.98
0.09
3.6
2.9
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
134
0.89
0.09
1.0
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
6
56
1.07
0.08
1.0
1.1
—
—
—
0
0
(4035726)
29
308
0.94
0.08
1.5
1.4
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
5
62
0.80
0.08
1.2
1.4
nmol/l
0.4
0.5
—
5
57
(36660697) Celiac disease serology panel - Serum
58
601
0.96
0.08
1.2
1.2
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
17
184
0.92
0.07
1.1
1.2
—
3.1
—
0
9
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
9
104
0.86
0.06
1.0
1.2
—
1.0
—
0
7
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
13
141
0.92
0.05
1.1
1.2
—
35.6
—
0
5
(3048929) Epstein Barr virus Ab [Presence] in Serum
36
346
1.04
0.05
1.9
1.5
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
10
91
1.10
0.04
3.9
3.0
u/ml
3.1
9.4
—
10
82
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
67
683
0.98
0.03
2.4
3.5
%
22.3
21.7
0.07
15
232
(3037522) Nuclear Ab [Titer] in Serum
73
717
1.02
0.03
1.4
1.4
titre
302.9
440.6
0.77
14
131
(3020961) Endomysium IgA Ab [Titer] in Serum
40
390
1.03
0.03
1.1
1.2
—
153.8
—
0
8
(3002256) Pathology report gross observation
49
500
0.98
0.02
1.2
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
18
172
1.05
0.02
2.5
2.2
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
12
113
1.06
0.02
1.1
1.2
—
38.5
—
0
8
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
16
153
1.05
0.01
1.9
2.0
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
141
1419
0.99
0.01
1.5
1.5
g/l
2.0
2.1
0.62
94
862
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
21
217
0.97
0.01
1.1
1.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
27
277
0.97
0.01
1.1
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
124
1232
1.01
0.01
5.9
4.7
—
—
—
0
0
(4034850)
15
146
1.03
0.00
8.3
8.9
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
19
186
1.02
0.00
2.6
1.5
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
11
108
1.02
0.00
1.0
1.1
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
13
132
0.98
0.00
1.0
1.2
—
3.8
—
0
15
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
13
132
0.98
0.00
1.0
1.2
—
13.6
—
0
22
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
31
307
1.01
0.00
1.7
1.7
—
—
—
0
0
(40768443) Skin Pathology biopsy report
16
162
0.99
0.00
1.2
1.2
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
48
477
1.01
0.00
2.4
2.3
nmol/l
13.2
13.8
0.15
39
432
(3026493) Urate [Moles/volume] in Serum or Plasma
98
977
1.00
0.00
3.0
2.9
umol/l
326.9
5004.0
3.11
79
888
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
16
161
0.99
0.00
1.4
1.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
363
3635
1.00
0.00
4.4
3.2
u/l
48.8
38.4
1.74
341
3492
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
6
65
0.92
0.00
1.0
2.5
g/l
0.0
0.0
—
6
65
(40765089) Chromosome analysis panel - Blood by G-banded
6
66
0.91
0.00
1.0
1.0
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
7
0.00
0.00
0.0
2.1
—
3.3
—
0
7
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
8
86
0.93
0.00
1.0
2.3
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
20
200
1.00
0.00
1.1
1.7
—
7.6
—
0
10
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine
0
5
0.00
0.00
0.0
1.8
—
424.4
—
0
5
(3007463) Buprenorphine [Presence] in Urine
0
8
0.00
0.00
0.0
6.0
—
—
—
0
0
(3039744) RNA polymerase III Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
7
71
0.99
0.00
1.3
1.2
—
—
—
0
0
(3000936) Kiwifruit IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
1.1
—
0
5
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
49
1.02
0.00
1.2
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
8
86
0.93
0.00
4.0
1.6
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
9
0.00
0.00
0.0
2.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
9
93
0.97
0.00
3.0
2.7
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
16.5
—
0
5
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
8
86
0.93
0.00
1.6
1.3
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
5
53
0.94
0.00
1.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint G6_CP and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_CP | 3.963 [3.08, 5.1] | < 0.001 |
| Birth year | 0.996 [0.99, 1.0] | 0.391 |
During the follow-up period (1.1.1998 — 31.12.2019), 237 out of 2065 females with G6_CP died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_CP | 4.157 [3.3, 5.24] | < 0.001 |
| Birth year | 0.988 [0.98, 1.0] | 0.01 |
During the follow-up period (1.1.1998 — 31.12.2019), 321 out of 2713 males with G6_CP died.
Mortality risk
Mortality risk for people of age
years, who have G6_CP.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.503% | 0.856% |
| 5 | 2.212% | 4.649% |
| 10 | 5.788% | 11.035% |
| 15 | 11.207% | 20.602% |
| 20 | 18.459% | 32.662% |
Relationships between endpoints
↥Index endpoint: G6_CP – Cerebral palsy
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data